|drug2183||Saline solution Wiki||0.29|
|drug185||Anti-SARS-CoV2 Serology Wiki||0.29|
|drug992||Gas exchanges at different PEEP Wiki||0.21|
|drug1920||Prone decubitus Wiki||0.21|
|drug724||Data collection up to 1 year Wiki||0.21|
|drug2846||hyperbaric oxygen therapy (HBOT) Wiki||0.21|
|drug1720||Oxygen-ozone therapy, probiotic supplementation and Standard of care Wiki||0.21|
|drug2397||Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors Wiki||0.21|
|drug1046||Hemodynamics changes at different PEEP Wiki||0.21|
|drug2303||Standard Donor Plasma Wiki||0.21|
|drug2222||Selitrectinib (BAY2731954) Wiki||0.21|
|drug2875||lung mechanics at different PEEP Wiki||0.21|
|drug645||Convalescent COVID 19 Plasma Wiki||0.21|
|drug186||Anti-SARS-CoV2 serological controls and serum neutralization Wiki||0.21|
|drug218||Aspirin 100mg Wiki||0.21|
|drug2244||Serum test Wiki||0.21|
|drug2534||Tocilizumab Injection Wiki||0.15|
|drug1376||Low Dose Radiation Therapy Wiki||0.15|
|drug2235||Serological test Wiki||0.15|
|drug2271||SivoMixx (200 billion) Wiki||0.15|
|drug1220||Interferon Beta-1B Wiki||0.12|
|drug1219||Interferon Beta-1A Wiki||0.10|
|drug1355||Lopinavir / Ritonavir Wiki||0.10|
|drug647||Convalescent Plasma Wiki||0.09|
|D012170||Retinal Vein Occlusion NIH||0.21|
|D005157||Facial Pain NIH||0.21|
|D002055||Burnout, Professional NIH||0.19|
|D008268||Macular Degeneration NIH||0.15|
|D008269||Macular Edema NIH||0.15|
|D000077062||Burnout, Psychological NIH||0.13|
|D003550||Cystic Fibrosis NIH||0.12|
|D018352||Coronavirus Infections NIH||0.09|
|D007153||Immunologic Deficiency Syndromes NIH||0.09|
|D045169||Severe Acute Respiratory Syndrome NIH||0.08|
|D003141||Communicable Diseases NIH||0.05|
|D055371||Acute Lung Injury NIH||0.04|
|D012127||Respiratory Distress Syndrome, Newborn NIH||0.04|
|D012128||Respiratory Distress Syndrome, Adult NIH||0.04|
|D011024||Pneumonia, Viral NIH||0.03|
There are 23 clinical trials
Descriptive prospective study to investigate the prevalence of COVID 19 during ambulant screening
Description: Prevalence of fever, cough, anorexia, fatigue, diarrhea, vomiting, dyspnee, sore throat and sputumMeasure: Prevalence of symptoms Time: at the ambulant screening
Description: Prevalence of positive COVID 19 tests in patients planned for surgery, treatment or investigation in the hospitalMeasure: Prevalence of positive Sars CoV-2 PCR Time: at the ambulant screening
Description: Prevalence of positive radiological findings in CT scans of the lungs of planned for surgery, treatment or investigation in the hospitalMeasure: Prevalence of positive radiological findings Time: at the ambulant screening
Description: Prediction of symptoms of COVID 19, based on evaluated baseline questionnaireMeasure: Prediction of symptoms Time: 2 weeks after surgery or treatment
Description: Prediction of symptoms of COVID 19, based on radiological findings of CT scansMeasure: Prediction of symptoms Time: 2 weeks after surgery or treatment
Description: Prediction of symptoms of COVID 19, based on COVID 19 PCR resultsMeasure: Prediction of symptoms Time: 2 weeks after surgery or treatment
A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO Country Office in China on 31 December 2019. The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020. The spread and severity of the disease is variable from one country to another. Our team as well as many reports suggested that in some countries a " Flu like illness but much worse" was described in October, November and early in December before the WHO announcement. Was it COVID-19?
Description: fever, dry cough, dyspnea, malaise, headacheMeasure: Measure frequency of people suffered from unusual flu-like symptoms before December 2019 Time: one month
Description: serum IgGMeasure: Measure remote immunity for COVID-19 in subject with past history of severe flu before WHO announcement date- if possible Time: 3 month
The outbreak linked to SARS-CoV-2 infection was declared a Public Health Emergency of International Concern on 30 January 2020. In all of the emergency Departments, a major reorganization was necessary, notably with the creation of a specific channel for COVID-19 suspect patients. Thus, all caregivers involved must adapt day by day to new places of exercise, new protocols,...The major influx of patients, the precautions to be taken, the specifics of the pathology and its management have profoundly changed daily practice. This exogenous hospital tension impacts all caregivers and more particularly their resilience capacities. Resilience is defined as an ability to recover from or adjust easily to misfortune or change. The Resi-CoV study aims to assess the level of resilience of caregivers of different specialties and trades in the context of covid-19.
Description: CD-RISC-25 : Connor-Davidson Resilience Scale - 25. This scale contain 25 questions each range from 1 to 5. The total is 100 points which means a very high level of resilience.Measure: compare the level of resilience between physicians and caregivers of different specialties and in different workplaces according to the covid-19 epidemic. Time: 14 days
"For 12 years, the odontology service of the Pitié-Salpêtrière hospital group (GHPS) has been responsible for day and night dental emergency care. Several surveys have been conducted in order to analyze the sociological characteristics of the patients and the typology of the acts performed. These studies indicate that pain is the main reason for consultations, cited by 60 to 80% of patients. So far, very few studies have been done in the context of emergencies. Very recently, a study was undertaken on the satisfaction of patients consulting the odontological emergencies of the GHPS, during a thesis work. This study, carried out in collaboration with the URC Pitié Salpêtrière, under analysis, relates to the satisfaction of patients consulting the odontological emergencies of the GHPS during the day and week, Monday to Friday, excluding night and week emergencies -end (WE). An additional study (URGDENT-NW) aiming at completing this study by focusing on patients consulting the emergency room at night and during the weekend is also in progress. The COVID19 Crisis changed the organization and the venue of patients at the emergency dental service. Therefore this project, based on the same protocol as URGENT and URGDENT-WE, aims at evaluating the Odontology Emergency Reception Service (SAUO) during the COVID 19 epidemy. It will be carried out in the form of a survey whose objective is to assess: on the one hand, the effectiveness of the care provided in this emergency functional unit, and on the other hand the satisfaction of the patients after their passage to the emergency room ."
Description: "Self report measure of pain on the numeric scale 24h after the visit "Measure: Pain score evolution measured by a 0-10 numeric scale (NS) where 0 is no pain and 10 the worst pain imaginable Time: Day 1
Description: the pain is measured with the numeric scaleMeasure: Pain scores evolution 3 days and 7 days after first visit measured by a numeric scale where 0 is no pain and 10 the worst pain imaginable Time: Day 3 and Day 7
Description: Perception of welcoming, waiting time will be measured with a 0-10 numeric scaleMeasure: welcoming quality from hospital staff Time: Day 1
Description: The patient anxiety will be measured by numeric scale at Day 0, Day 1, Day 3, Day 7Measure: anxiety score Time: Day 0, Day 1, Day 3, Day 7
Description: The perception is measured just after care with a 0-10 numeric scaleMeasure: perception of the technical quality of the emergency treatment Time: Day 1
This original study will assess the impact of the coronavirus health crisis on the management of patients undergoing medical treatment for cancer, in particularly on the modification of the hospital organization. It will also provide a record of the progress of patients who will have been treated during the epidemic period and infected by the virus. We will also assess the psychological impact of the pandemic in patients but also in caregivers
Description: Proportion of patients with modification of the treatments administeredMeasure: To assess the impact of the COVID-19 pandemic on the modifications of treatments administered in hospital (day units) to patients with cancer or malignant hemopathy Time: up to 6 months
Description: Proportion of patients with change in the rate of treatment administrationMeasure: To assess the impact of the COVID-19 pandemic on the change in the rate of treatment administration in hospital (day units) to patients with cancer or malignant hemopathy Time: up to 6 months
Description: Proportion of patients with change in the number of cures administeredMeasure: To assess the impact of the COVID-19 pandemic on the number of cures administeredin hospital (day units) to patients with cancer or malignant hemopathy Time: up to 6 months
Description: Proportion of patients with change of modality of administration (home administration to replace day hospital administration, teleconsultation uses)Measure: To assess the impact of the COVID-19 pandemic on change of modality of administration in hospital (day units) to patients with cancer or malignant hemopathy Time: up to 6 months
Description: Score of questionnaires of Perceived Stress Scale [0-40 points]Measure: Evaluate the perceived stress on cancer patients treated in unit day of hospital Time: up to 6 months
Description: Score of questionnaires of Impact of Event Scale-Revised [0-88 points]Measure: Evaluate the post-traumatic stress on cancer patients treated in unit day of hospital Time: up to 6 months
Description: Score of questionnaires of sleep disorders (ISI scale, 0-28 points)Measure: Evaluate the sleep disorders on cancer patients treated in unit day of hospital Time: up to 6 months
Description: Score of questionnaires of quality of life (FACT-G scale)Measure: Evaluate the quality of life on cancer patients treated in unit day of hospital Time: up to 6 months
Description: Score of questionnaires of cognitive complaints (Fact-Cog scales; 0-148 points)Measure: Evaluate the cognitive complaints on cancer patients treated in unit day of hospital Time: up to 6 months
Description: Score of questionnaires of Perceived Stress Scale [0-40 points]Measure: Evaluate the perceived stress on caregivers (perceived stress, post-traumatic stress, burnout, feeling of personal effectiveness) Time: up to 3 months
Description: Score of questionnaires of Impact of Event Scale-Revised [0-88 points]Measure: Evaluate the post-traumatic stress on caregivers (perceived stress, post-traumatic stress, burnout, feeling of personal effectiveness) Time: up to 3 months
Description: Score of questionnaires of burnout ((Maslach Burn Out Inventory scale, 0-132 points)Measure: Evaluate the burnout on caregivers (perceived stress, post-traumatic stress, burnout, feeling of personal effectiveness) Time: up to 3 months
Description: Score of questionnaires of feeling of personal effectiveness (0-30 points)Measure: Evaluate the feeling of personal effectiveness on caregivers (perceived stress, post-traumatic stress, burnout, feeling of personal effectiveness) Time: up to 3 months
The investigators plan to perform an observational study to evaluate the prevalence of burnout, depression and medical errors in a designated exclusive Covid-19 patients hospital in Malaysia, during the Covid-19 pandemic. In addition, the relationship between burnout and depression with medical errors will be assessed. The population studied will be the nurses working in the Intensive Care Unit, who are at higher risk due to the nature of their work at the frontlines of the pandemic.
Description: Prevalence of burnout riskMeasure: Prevalence of burnout among ICU nurses during Covid-19 Time: 2 months
Description: Prevalence of depression riskMeasure: Prevalence of depression among ICU nurses during Covid-19 Time: 2 months
Description: Prevalence of self perceived medical errorsMeasure: Prevalence of self-perceived medical errors among ICU nurses during Covid-19 Time: 2 months
Description: To find out if there exists a relationship between burnout, depression and medical errorsMeasure: Association of burnout, depression and medical errors among anaesthesiology clinicians during Covid-19 Time: 2 months
The term "sleep hygiene" refers to a series of healthy sleep habits that can improve the ability to fall asleep. These habits are the most effective long-term treatment for people with chronic insomnia. The "Sleep Hygiene Index" is a 13-item questionnaire that evaluates these habits. We are in the process of validation of this questionnaire in the arabic language. We will evaluate these habits in the Lebanese population during the COVID-19 confinement period.
A weekly questionnaire is sent to patients and parents of patients who are vulnerable for infections. Possible symptoms of COVID19 are asked for and use of healthcare services and testing for COVID19. Weekly reports are being send to the national institutions to update advice given to this group.
Description: To describe frequency of cough, fever, diarrhoea, shortness of breath, sore throat, blocked nose, red eyes, headache, joint pain, muscle pain, fatigue, chills, nausea, vomiting, diarrhoea over a yearMeasure: To describe COVID19 infection in children/adults who are vulnerable for infection in an outpatients setting Time: 1 year
Description: Patient/parent reported positive tests for COVID19Measure: Number of children/adults tested positive for COVID19 Time: 1 year
Description: Patient/parent reported admissions in hospital because of COVID19Measure: Number of children/adults admitted in hospital because of COVID19 Time: 1 year
Description: Patient/parent reported effect of COVID19 on daily activitiesMeasure: To assess the impact of COVID19 infection on the daily activities of immunosuppressed adults and children Time: 1 year
It has been suggested that ibuprofen might be associated with more severe cases of coronavirus infections, based on the observation that severe COVID cases had been exposed to ibuprofen, resulting in a warning by the French authorities. This was attributed to: 1. a suggestion that ibuprofen might upregulate ACE-2 thereby increasing the entrance of COVID-19 into the cells, 2. an analogy with bacterial soft-tissue infections where more severe infections on NSAIDs are attributed to an immune-depressive action of NSAIDs, or to belated treatment because of initial symptom suppression, 3. fever is a natural response to viral infection, and reduces virus activity: antipyretic activity might reduce natural defenses against viruses. However fever reduction in critically ill patients had no effect on survival. However, these assertions are unclear: upregulation of ACEII would increase the risk of infection, not necessarily its severity, and would only apply to the use of NSAIDs before the infection, i.e. chronic exposure. It would be irrelevant to the infection once the patients are infected, i.e., to symptomatic treatment of COVID-19 infection. Anti-inflammatory effect masking the early symptoms of bacterial infections resulting in later antibiotic or other treatment is not applicable: there is no treatment of the virus that might be affected by masking symptoms. Antipyretic effect increasing the risk or the severity of infection would apply equally to all antipyretic agents including paracetamol, which share the same mechanism of action for fever reduction. EMA remains prudent about this assertion In addition, excess reliance on paracetamol while discouraging the use of ibuprofen might increase the risk of hepatic injury from paracetamol overdose. Paracetamol is the prime drug associated with liver injury and transplantation, in voluntary and inadvertent overdose or even at normal doses. This might be increased by COVID-related liver function alterations. It is therefore proposed to conduct a case-control study in a cohort of patients admitted to hospital in France with COVID-19 infection.
Description: Describe medications including ibuprofen used prior to admission associated with worse infection in COVID-19 patients in France. Thanks to a questionnaire created for the study, with 5 questions on existing pathology, drugs administrated symptom onset and when, hospitalisation. Each questions have a multiple choice.Measure: Describe medications used prior to admission associated with worse infection in COVID-19 patients in France. Time: At inclusion day
Description: Quantify medications including ibuprofen used prior to admission associated with worse infection in COVID-19 patients in France. Thanks to a questionnaire created for the study, with 5 questions: existing pathology, drugs administrated symptoms onset and when, hospitalisation. Each questions have a multiple choice.Measure: Quantify medications used prior to admission associated with worse infection in COVID-19 patients in France. Time: At inclusion day
Description: Describe patient characteristics thanks to the same questionnaire.Measure: Describe other patient characteristics with worse infection in COVID-19 patients in France. Time: At inclusion day
Description: Quantify patient characteristics thanks to the same questionnaire.Measure: Quantify other patient characteristics with worse infection in COVID-19 patients in France. Time: At inclusion day
Emerging in China in December 2019, Covid-19, whose pathogen is SARS-Cov-2, was declared a global pandemic in March 2020. The clinical presentation is highly variable, ranging from asymptomatic forms to acute respiratory distress and even death. Transmission occurs through droplets, with a R0 of approximately 3. Rapidly, population protection measures were put in place by governments, including the confinement of all persons whose functions were not considered essential and the closure of educational institutions. Health care institutions are places at risk of Covid-19 transmission and hospital staff are particularly exposed, either through direct contact with patients, contact with exposed persons or through the environment. In order to protect personnel, hygiene measures were immediately recalled and reinforced. This study is aimed at evaluating the incidence rate of anti-SARS-Cov2 seroconversion over 2 months among hospital staff, without any supposed anti-Covid treatment 19.
Description: Change of Anti-SARS-Cov2 serological status between Day 0 and Day 60, measured in blood sample.Measure: Anti-SARS-Cov2 seroconversion between Day 0 and Day 60. Time: From Day 0 to Day 60
Description: Change of Anti-SARS-Cov2 serological status between Day 0 and Day 30, measured in blood sample.Measure: Anti-SARS-Cov2 seroconversion between Day 0 and Day 30. Time: From Day 0 to Day 30
Description: Change of Anti-SARS-Cov2 serological status between Day 30 and Day 60, measured in blood sample.Measure: Anti-SARS-Cov2 seroconversion between Day 30 and Day 60. Time: From Day 30 to Day 60
Description: Anti-SARS-Cov2 seroprevalence measured in blood sample collected at Day 0.Measure: Anti-SARS-Cov2 seroprevalence at Day 0. Time: Day 0
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and sexMeasure: Correlation between seroconversion and socio-demographic factors - sex Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and ageMeasure: Correlation between seroconversion and socio-demographic factors - age Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and job type (nurse, physician, etc.)Measure: Correlation between seroconversion and professional factors - job type Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and personal protective equipment typeMeasure: Correlation between seroconversion and professional factors - personal protective equipment type Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and contact with infected individualsMeasure: Correlation between seroconversion and non-professional factors - contact with infected individuals Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and wearing of professional equipmentMeasure: Correlation between seroconversion and non-professional factors - wearing of professional equipment Time: Day 60
Description: Correlation between seroconversion (measured in blood sample) at Day 60 and respect of barrier gesturesMeasure: Correlation between seroconversion and non-professional factors - respect of barrier gestures Time: Day 60
In patients treated for exudative age-related macular degeneration (AMD), diabetes, retinal venous occlusion (OVR), or other conditions causing macular edema, treatments with anti-angiogenic intravitreal injections (IVT) are widely used both for their anti-angiogenic action. Patients often have injections for many years, sometimes monthly or every 2 months. The discontinuation of treatment with repeated injections of anti-angiogenic agents, linked to the COVID-19 coronavirus pandemic will potentially impact the visual acuity, the ophthalmological state and the quality of life of the patients concerned, therefore it is relevant to analyze the consequences the breakdown of usual care in this population.
Description: Change from baseline (last visual acuity before confinement) and visual acuity 6 months after resumption of follow-upMeasure: Change of visual acuity in patients treated with repeated IVT anti-angiogens during the COVID-19 epidemic Time: Baseline (Before confinement) and 6 months after resumption of follow-up
The COVID-19 pandemic brought new challenges to our nationwide healthcare system, with rapid escalation of the number of affected individuals over a handful of weeks. From March 13, a first set of measures was taken to minimise the spread of the virus, which largely impacted societal and economical daily life. A view days later, on March 17, the country was put in "lockdown" and all non-urgent medical treatments were cancelled or postponed. As recommended by the major scientific fertility societies, all non-ivf fertility treatments were discontinued abruptly, whereas started ivf stimulations were continued until oocyte aspiration, where after a freeze-all strategy was applied. There is little information available for women aiming for pregnancy or embarking on assisted conception. Given the modelling of the pandemic, including the time to peak and subsequent tail, considerable delays in conception to substantially attenuate risk may be required, which will inevitably impact patients wellbeing and overall success rates. A questionnaire was developed to explore patients perspectives on different aspects of their fertility treatment during the COVID-19 pandemic. The questionnaire contains the following sections: - demographic variables; - questions regarding the fertility history of the respondent; - questions regarding the impact of fertility treatment cancellation / postponing fertility treatment during COVID-19 on their life, psychological wellbeing and relationship; - questions regarding continuing medical treatment on their own, or seeking treatment elsewhere; - questions regarding the satisfaction of measures taken by their fertility center regarding the COVID-19 pandemic; - questions regarding expectations of further treatments, with focus on safety issues related to the COVID-19 pandemic. Eligible patients will be selected electronically from our database and digital agenda. After selection, patients will be contacted via email to participate. Two reminders will be send in case the questionnaire is not filled out: a first reminder after one week, a second reminder after two weeks.
Doctors are at high risk of corona virus infection (COVID-19) during pandemic. The investigators are aiming to explore the emotions, perceived stressors, knowledge and coping strategies of doctors who are working during COVID-19 pandemic in different specialties and in different hospitals by a self assessment questionnaire that was designed and modified from two previously published articles (mentioned in the references), including 7 sections with 88 questions.
Description: Highlighting the emotional aspects, perceived stressors, level of knowledge and coping strategies of doctors who are working during COVID-19 pandemic in different hospitals by using questionnaires that the investigators gave the name "COVID-19 Doctor Stress Questionnaire" that included 7 sections with 88 questions: Demographic data related questions Doctors feelings related questions Factors that help in stressing doctors Factors help in reducing stresses Questions detecting knowledge Attitude towards stresses Motives to complete work Each is answered by the participant and assessedMeasure: Cross-sectional descriptive study: Egyptian Doctors Stresses, Knowledge and Attitude during COVID-19 Pandemic Time: 2 months
In mid-February 2020, within the Oise (France) cluster, a case of COVID-19 disease caused by a SARS-CoV2 infection was described among the personnel of the Creail Air Force Base (BA110). This resulted in the beginning of an epidemic controlled by epidemiological measures. One month later, containment measures were taken at the national level, measures that also applied to BA110 personnel. These personnel, exposed to both the initial phase of the epidemic and national protection measures, represent an extremely interesting population for understanding the epidemiological dynamics of the virus, particularly at a time when France is lifting the containment measures. It becomes extremely important to understand the levers of viral spread in order to adjust the health measures to be maintained as best as possible. The main objective of this study is to determine the extent of virus diffusion in this highly circulating population, as evidenced by several identified cases of COVID-19.
Description: The percentage of the study population with positive serological status will be determined. ELISA serology test will be used to detect anti-SARS-CoV2 antibodies (IgG and IgM) at Day 0Measure: Proportion anti-SARS-CoV2 seropositive Time: Day 0
Description: Among anti-SARS-CoV2 seropositive participants, the percentage of asymptomatic participants will be determined. COVID-19 symptoms will be measured using a questionnaire.Measure: Proportion of asymptomatic anti-SARS-CoV2 seropositive participants Time: Day 0
Description: The serological results obtained using the reference ELISA test results (detecting the presence of IgG and IgM antobodies) and using a second ELISA test detecting the presence of antibodies specifically directed against the Receptor Binding Domain and the Spike protein trimer of SARS-CoV2 virus will be compared.Measure: Agreement between the anti-SARS-CoV2 serological results obtained using two different techniques (detecting the presence of different antibodies) Time: Day 0
Description: Among anti-SARS-CoV2 seropositive participants, the percentage of participants with a positive response to serum neutralization will be determined.Measure: Proportion of serum neutralization positive Time: Day 0
Description: The evolution of the antibody level over time will be determined using repeated serodiagnoses at 3 and 9 months.Measure: Change of antibody level over time Time: 3 months and 9 months after Day 0
The lockdown of the French population is a health measure put in place in response to the pandemic linked to a new coronavirus, SARS-CoV-2 (Covid-19). After a health campaign to recommend hygienic "barrier gestures" and social distancing, the decision to confine the population at the national level was decided by the executive from Monday 16 March to Monday 11 May 2020. The national confinement implies the restriction of movement to the strict necessary, outings near the home and the closure of schools and communities. These decisions have led to an unprecedented state of stress for the entire French population, the consequences of which are unknown in the short, medium or long term. The objectives of this study are to evaluate the psychological impact of the confinement on adolescents with or without chronic disease and also the difficulties and fears engendered by deconfinement .
Description: Scale 0-21Measure: Anxiety score from the Generalized Anxiety Disorder 7 (GAD-7) questionnaire Time: At inclusion
Description: Scale 0-60Measure: Depression score from the Adolescent Depression Rating Scale (ADRS) questionnaire Time: At inclusion
Description: 8 items that are scored on a four-point scale and 3 sub scales: intrusion (4 items); avoidance (4 items) and arousal (5 items)Measure: Post traumatic score questionnaire: Children's Revised Impact of Events Scales -CRIES13 Time: At inclusion
Description: a question on the quality and quantity of sleep will be asked to the teenager on a questionnaireMeasure: Presence or absence of difficulty in falling asleep, sleeping Time: At inclusion
Description: a question on the presence or absence of feeding difficulty will be asked to the teenager on a questionnaireMeasure: Presence or absence of feeding difficulty Time: At inclusion
Description: a question on the presence or absence of difficulty performing physical activity will be asked to the teenager on a questionnaireMeasure: Presence or absence of difficulty performing physical activity Time: At inclusion
Description: a question on the presence or absence of toxic consomption will be asked to the teenager on a questionnaireMeasure: Presence or absence of toxic consomption (drug, acohol) during the lockdown Time: At inclusion
Description: A question on the presence or absence of difficulties with social interactions will be asked to the teenager on a questionnaireMeasure: Presence or absence of difficulties with social interactions Time: At inclusion
Description: Presence or absence of difficulties with familial interactionsMeasure: Presence or absence of difficulties with familial interactions Time: At inclusion
Empathy, which can be briefly defined as understanding and feeling of one's thoughts upon experiences. It has been gaining importance in health care. A great majority of the literature has been focusing on the aspect of physician and health care provider yet recently establishing or measuring empathy has been performed with the undergraduate students. Since empathy and its related dimensions are important to integrate a better skill to provide in health care, measuring empathy gained attention. However, there might be lacking some tools which assess empathy directly such as the Empathic Tendency Scale and the Empathic Skill Scale in the Turkish language, yet these were discussed as cannot be quite modifiable to some specific sub-groups such as health sciences students. Thus, this study is aimed to study for the reliability, validity, and cross-cultural adaptation of the Turkish version of the Jefferson Scale of Empathy for undergraduate health care students.
Description: The Turkish version of Jefferson Scale of Empathy Health Professional Students (JSE-HPS) will be applied to participants. The minimum and maximum scores for JSE-HPS can be reached to 20 and 140, respectively. The more the higher scores indicate more empathic aspect or vice versa.Measure: Jefferson Scale of Empathy Health Professional Students Questionnaire Time: Baseline
Description: The Turkish version of Jefferson Scale of Empathy Health Professional Students (JSE-HPS) will be applied to participants. The minimum and maximum scores for JSE-HPS can be reached to 20 and 140, respectively. The more the higher scores indicate more empathic aspect or vice versa.Measure: Jefferson Scale of Empathy Health Professional Students Questionnaire Time: 1 week after baseline
Description: The Turkish version of Empathic Tendency Scale (ETS) Questionnaire will be applied to participants. The minimum and maximum scores can be taken from the tool are 20 and 100, respectively in which higher scores indicate better empathic attitude or vice versa.Measure: Empathic Tendency Scale (ETS) Questionnaire Time: Baseline
Description: Basic Form gathers some information related participants' age, gender etc.Measure: Demographic Data Form Time: Baseline
This is a cross-sectional survey which will be distributed online between surgeons. The survey was proposed by a consensus of consultants of surgery and revised by an improvement consultant. It consists of a semi-structured questionnaire that is provided in English language. The survey will be conducted online through an online survey development cloud-based software (SurveyMonkey®; San Mateo, CA, USA). Participants will be aware of the nature of the survey and informed that they will be listed as co-authors. Collected data will be confidential and anonymous. The first sector of the questionnaire includes trainee demographics and baseline characteristics. Then the questionnaire aims to compare the trainee experience before and after the pandemic with focus on research activities, clinical, and surgical practice.
Description: A questionnaire designed based on the literature review to assess BurnoutMeasure: Change in Burnout before COVID-19 and during COVID-19 Time: 1 year before COVID-19 versus during the COVID-19 pandemic (Mrach-June 2020)
Description: A questionnaire designed based on the literature review to assess Job satisfactionMeasure: Change in Job satisfaction before COVID-19 and during COVID-19 Time: 1 year before COVID-19 versus during the COVID-19 pandemic (Mrach-June 2020)
A questionnaire is developed based on the literature and clinical experience. Initial testing will be performed on 20 patients. The first and second sectors include patient demographics and patient clinical diagnosis/scheduled surgery, respectively. The following sectors examine the process of delivering the cancellation/re-scheduling; care after cancellation and whether the procedure conducted elsewhere or not; and the impact of cancellation on patient health, career, and financial aspects.
Description: A questionnaire based on the literature review to access the quality of the life of the patientsMeasure: Quality of Life of the patients Time: During the COVID-19 pandemic 6 months (March-October 2020)
Hospital mortality attributed to SARS-CoV-2 in France increased daily by 28% in the week before confinement. The week following this decision, the daily increase was 30%. During the week of the second week of confinement, it started a decline of 19% estimated over the last 5 days, reaching the cumulative number of 2606 deaths on 29/3 (site https://www.eficiens.com/coronavirus- personal statistics / and calculation). The diagnosis of viral carriage by RT-PCR is reserved for symptomatic cases among caregivers, due to the shortage of available tests and the cumbersome implementation. The carrier diagnosis is the benchmark, on which are implemented the therapeutic strategies and established the national statistics. It can present false negatives, linked to a research too early or too late in relation to the infection, or to a technical defect of the nasal swab sample. Caregivers on the front line in patient care, in hospitals or in the city, have only partial access to this diagnostic test, depending on the existence of symptoms. The implementation of a systematic serological screening, planned by the government and which cannot be based only on the search for the virus, will make it possible to inform the caregivers presenting symptoms or not, of their serological status, and therefore of their degree immunity or, on the contrary, susceptibility to infectious contacts. It should therefore be very voluntarily requested. On the occasion of this screening, the constitution of the COVID-3S cohort will make it possible to verify the degree of contamination in an asymptomatic population, information which is sorely lacking for the estimation of the immune coverage of the population. The implementation of the Covid-3S study will be based on the work of the National Reference Center of Pr B Lina, from the COVID-SER cohort, for the selection of the most efficient test (s). It seems useful to initiate the constitution of this cohort as soon as possible in relation to the evolution of the epidemic. Pending receipt of official recommendations, the lack of knowledge of the performance of serological tests means that it should be applied first to health professionals, better able to appreciate its limits, for the initial period before determining a validated serological screening strategy. Once the strategy has been specified, the gradual expansion of screening to the patient population will provide a more representative basis for the construction of epidemiological models for evaluating strategies.
Description: Estimated number of deaths avoided by the various population protection strategies, estimated by applying these strategies to the realistic virtual population.Measure: Establishment of a reliable prediction model for the effectiveness of virus control Time: 18 months
Non-urgent medical care, such as fertility treatments, has been massively postponed during the past weeks due to the COVID19 pandemic. The lockdown and the closure of IVF centers might cause anxiety and depression among infertile couples, who are already exposed to the distressing experience of infertility and for whom the wait for a baby already appears unending. Few data are available regarding the impact of SARS-CoV-2 on pregnant women and foetus, or on fertility. This study aims to assess the views of infertile couple regarding the potential risks of COVID during their fertility treatment and their personal experience of the COVID pandemic and their expectation for further treatment .
Description: Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment, via a surveyMeasure: Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment pandemic and the discontinuation Time: 1 day
Description: . Risk assessment by the patient, via a survey, regarding SARS-CoV-2 during a fertility treatment or during pregnancy. Perception of the risks linked to SARS-CoV-2 during their fertility treatment or during a pregnancyMeasure: Risk assessment Time: 1 day
Description: Patients'expectations regarding the management of an abrupt closure of the fertility center, via a surveyMeasure: Patients'expectations regarding the management of an abrupt closure of the fertility center Time: 1 day
Impacts of the Covid-19 epidemic and associated lockdown measures on the management, health and behaviors of cystic fibrosis patients during the 2020 epidemic
Description: Number of consultations cancelled or postponed by the health professional or patient of consultations (medical and paramedical),Measure: Cancellation or postponement of consultations by the health professional or patient, Time: Up to 6 months
Description: Number of consultations cancelled by the teleconsultation/replacement patient,Measure: Patient cancellation of teleconsultations/telecare replacement, Time: Up to 6 months
Description: Number of consultations cancelled or postponed by the health care institution or by the patient of hospitalizations (acute or scheduled)Measure: Cancellation or postponement by the health care institution or by the patient of hospitalizations (scheduled or unscheduled), Time: Up to 6 months
Description: Number of patients affected by the change in the modality of administration of antibiotic cures (intravenous instead of intravenous administration).Measure: Change in the modalities of administration of antibiotics cures (oral instead of intravenous administration). Time: Up to 6 months
Description: Cancellation or postponement by the patient of consultations (medical or paramedical) Patient cancellation of teleconsultations/telecare proposed by the health professional Cancellation or postponement by the patient of hospitalizations (acute or scheduled)Measure: The reduction of each of the elements of care provision and health care utilization: Time: Up to 6 months
Description: Intravenous instead of intravenous administrationMeasure: The change of modality of administration of antibiotic cures Time: Up to 6 months
Description: Questionnaire about taking or not taking treatment during confinementMeasure: Compliance Time: Up to 6 months
Description: Scale 0-21Measure: Anxiety and stress (at risk of being affected by COVID-19 or at risk of being treated less well) Time: Up to 6 months
Description: A questionnaire on the presence or absence of toxic consumptionMeasure: Presence or absence of toxic consumption (drug, alcohol) during the lockdown Time: Up to 6 months
Description: Experience and social representations of confinement by cystic fibrosis patients (evaluated by qualitative methods)Measure: Evaluation of the knowledge, experience and social representations of the risk of Covid-19 Time: Up to 6 months
Description: Role of social inequalities in the consequences of containment assessed by qualitative methodsMeasure: Assessing the role of social inequalities in the consequences of lockdown Time: Up to 6 months
Description: Prevalence of suspected and/or confirmed Covid-19 infections in patients with cystic fibrosisMeasure: Suspected and/or confirmed Covid-19 in patients with cystic fibrosis. Time: Up to 6 months
Spread of COVID-19 in the world has led to a shift in teaching and learning techniques to online methods in order to prevent transmission of the disease. Misr International University (MIU) has an established online learning system that has been used together with face-to-face classes. The aim of this study is to assess and compare the satisfaction and perceptions of full-time teaching staff and undergraduate students regarding online learning during COVID-19 crisis.
Description: Assess level of satisfaction with online learning using a questionnaireMeasure: Satisfaction with online learning Time: 1 month
Description: Assess level of knowledge about COVID-19 using a questionnaireMeasure: Knowledge about COVID-19 crisis Time: 1 month
Description: Assess level of perception of COVID-19 crisis using a questionnaireMeasure: Perception of COVID-19 crisis Time: 1 month
The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.
Description: Extent of improvement of vision-related qualitiy of life due to cataract surgery measured with the National Eye Institut Visual Function Questionnaire 25.Measure: Improvement Vision-related quality of life Time: 3 months
Description: Delay of improvement of vision-related qualitiy of life in the COVID-19 pandemic measured in days between the originally scheduled operation and the actual operation dateMeasure: Delay of Vision-related quality of life Time: 3 months
Description: Visual acuity difference between visual acuity at the time of indication for cataract surgery, on the day of surgery and one month postoperatively.Measure: Visual acuity Time: 1 month